Sina Kazemian

EDUCATION

(Sep. 2020 – Mar. 2024) Cardiovascular Research Diploma, Tehran University of Medical Sciences

(Sep. 2014 – Jan. 2022) M.D., School of Medicine, Tehran University of Medical Sciences

RESEARCH EXPERIENCE

(Sep. 2018 – Present) Cardiovascular Diseases Research Institute, Tehran Heart Center

• Conducted clinical research on cardiovascular manifestations of COVID-19, cardiovascular diseases, and cardiac arrhythmias.

(Jul. 2022 – Present) GBD collaborator at Institute for HME, University of Washington

• Epidemiological research on global, regional, and national burden of diseases, particularly cardiovascular diseases.

(Aug. 2024) USERN 7th Lab Techniques School

• Molecular Tests (DNA extraction & PCR)
• Flow Cytometry
• Cell Culture
• Western Blot

(Dec. 2023) DeepLearning.AI, Stanford University, Online Specialization

• "Machine Learning" specialization (3 courses) offered through Coursera.

(May. 2023) Imperial College London, Online Specialization

• "Statistical Analysis with R for Public Health" specialization (4 courses) offered through Coursera.

(Dec. 2021) Johns Hopkins University, Online Research Course

• "Introduction to Systematic Review and Meta-Analysis" course offered through Coursera.

(Dec. 2019 – Jun. 2021) Research Development Center, Sina Hospital

• Development and management of the COVID-19 registry database at Sina Hospital.
• Conducted clinical research on COVID-19 and its complications.

PUBLICATIONS

1. Kazemian S, et al. Stroke Risk After Mitral Valve Interventions: A Systematic Review and Network Meta-Analysis. The American Journal of Cardiology 2024.

2. Kazemian S, et al. Risk scores for prediction of paroxysmal atrial fibrillation after acute ischemic stroke or transient ischemic attack: A systematic review and meta-analysis. International Journal of Cardiology: Cardiovascular Risk and Prevention 2024.

3. Kazemian S, et al. Meta-Analysis on the Association Between Nutritional Status and Outcomes After Transcatheter Aortic Valve Implantation. The American Journal of Cardiology 2022.

4. Kazemian S, et al. Challenges in developing and validating machine learning models for transcatheter aortic valve implantation mortality risk prediction. European Heart Journal - Digital Health 2023 (Letter).

5. Kazemian S, et al. Reply to the commentary "Liquid gold: do we need to fraction fresh colostrum for oral immunotherapy in premature infants?". International Breastfeeding Journal 2022 (Letter).

6. Siddiqui S, Kazemian S, et al. Outcomes of Transcatheter Aortic Valve Replacement Using Third-Generation Balloon-Expandable Versus Self-Expanding Valves: A Meta-Analysis. Journal of the Society for Cardiovascular Angiography & Interventions 2024.

7. Shafiee A*, Kazemian S*, et al. Epidemiology and prevalence of dyslipidemia among adult population of Tehran: the Tehran cohort study. Archives of Iranian Medicine 2024.
* Contributed as co-first authors.

8. Tavolinejad H*, Kazemian S*, et al. Effectiveness of conduction system pacing for cardiac resynchronization therapy: A systematic review and network meta‐analysis. Journal of Cardiovascular Electrophysiology 2023.
* Contributed as co-first authors.

9. Ghasemi H*, Kazemian S*, et al. Takotsubo syndrome and COVID-19: A systematic review. Health Science Reports 2022.
* Contributed as co-first authors.

10. Hadadi A*, Kazemian S*, et al. Effects of angiotensin receptor blockers (ARBs) on clinical outcomes of patients with hypertension and COVID-19: A 7-month follow-up cohort study. Journal of Cardiovascular and Thoracic Research 2022.
* Contributed as co-first authors.

11. Soleimani A*, Kazemian S*, et al. Effects of angiotensin receptor blockers (ARBs) on in-hospital outcomes of patients with hypertension and confirmed or clinically suspected COVID-19. American Journal of Hypertension 2020.
* Contributed as co-first authors.

12. Shafeghat M, Kazemian S, et al. Toll-like receptor 7 regulates cardiovascular diseases. International Immunopharmacology 2022.

13. Mozafar M, Kazemian S, et al. The glucocerebrosidase mutations and uric acid levels in Parkinson’s disease: a 3 years investigation of a potential biomarker. Clinical Parkinsonism & Related Disorders 2022.

14. Rahimzadeh H, Kazemian S, et al. The risk factors and clinical outcomes associated with acute kidney injury in patients with COVID-19: data from a large cohort in Iran. Kidney and Blood Pressure Research 2021.

15. Rashedi S, Tavolinejad H, Kazemian S, et al. Efficacy and safety of same‐day discharge after atrial fibrillation ablation: A systematic review and meta‐analysis. Clinical Cardiology 2022.

16. Hadadi A, Pirzadeh M, Kazemian S, et al. COVID-19 in Iran: clinical presentations and outcomes in three different surges of COVID-19 infection. Virology Journal 2022.

17. Chichagi F, Hadadi A, Kazemian S, et al. The Association Between Baseline Vitamin D Level and Clinical Outcomes in Patients With COVID-19: A 7-Month Follow-up Cohort Study. Topics in Clinical Nutrition 2023.

18. Shafie M, Moghadasi AN, Kazemian S, et al. The Impact of COVID-19 Pandemic on Physical Activity and Health Measures in Patients With Multiple Sclerosis. Acta Medica Iranica 2023.

19. Fallahi M, Babaei G, Kazemian S, et al. Predictors of Early Mortality in Esophageal Atresia: A 12-year Cohort Study in Tehran, Iran. Iranian Journal of Pediatrics 2022.

20. Ashraf H, Ghafouri P, Kazemian S, et al. Hydroxychloroquine alone or in combination with azithromycin and corrected QT prolongation in COVID-19 patients: A systematic review. World Journal of Meta-Analysis 2021.

21. Oraii A, Shafeghat M, Ashraf H, Soelimani A, Kazemian S, et al. Risk Assessment for Mortality in Patients with ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Retrospective Cohort Study. Health Science Reports 2024.

22. Pazoki M, Chichagi F, Hadadi A, Kafan S, Montazeri M, Kazemian S, et al. Association of clinical characteristics, antidiabetic and cardiovascular agents with diabetes mellitus and COVID-19: a 7-month follow-up cohort study. Journal of Diabetes & Metabolic Disorders 2021.

23. Issaiy M, Ghanaati H, Kolahi S, Shakiba M, Jalali AH, Zarei D, Kazemian S, et al. Methodological insights into ChatGPT’s screening performance in systematic reviews. BMC Medical Research Methodology 2024.

24. Fallahi M, Shafiei SM, Taleghani NT, Shariati MK, Noripour S, Pajouhandeh F, Kazemian S, et al. Administration of breast milk cell fractions to neonates with birthweight equal to or less than 1800 g: a randomized controlled trial. International Breastfeeding Journal 2021.

25. Pazoki M, Keykhaei M, Kafan S, Montazeri M, Hazaveh MM, Sotoodehnia M, Kazemian S, et al. Risk indicators associated with in-hospital mortality and severity in patients with diabetes mellitus and confirmed or clinically suspected COVID-19. Journal of Diabetes & Metabolic Disorders 2021.

26. Hadadi A, Ajam A, Montazeri M, Kafan S, Veisizadeh A, Ghoghaei M, Kazemian S, et al. Effects of Remdesivir on in-Hospital and Late Outcomes of Patients With Confirmed or Clinically Suspected COVID-19: A Propensity Score-Matched Study. Acta Medica Iranica 2022.

27. Soleimani A, Nayebi S, Ashraf H, Sadat Naseri A, Oraii A, Kazemian S, et al. Clinical and angiographic predictors of suboptimal coronary flow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. ARYA Atherosclerosis Journal 2022.

28. Global Burden of Cardiovascular Diseases and Risks Collaborators. Global Burden of Cardiovascular Diseases and Risks, 1990-2022. Journal of the American College of Cardiology 2023.

29. GBD 2019 Peripheral Artery Disease Collaborators. Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Global Health 2023.

30. GBD 2021 Forecasting Collaborators. Burden of disease scenarios for 204 countries and territories, 2022–2050 a forecasting analysis for the Global Burden of Disease Study 2021. The Lancet 2024.

31. GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet 2024.

32. GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet 2024.

33. GBD 2021 Demographics Collaborators. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. The Lancet 2024.

34. GBD 2019 IMID Collaborators. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019. eClinicalMedicine 2023.

35. GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet 2023.

36. GBD 2019 Iran MRF Collaborators. Metabolic risk factors attributed burden in Iran at national and subnational levels, 1990 to 2019. Frontiers in Public Health 2023.

PRESENTATIONS

1. Effects of angiotensin receptor blockers (ARBs) on clinical outcomes of patients with hypertension and COVID-19: A 7-month follow-up cohort study. The 5th International Congress of Pharmacy-Updates, February 2022; Poster Presentation; Role: Presenter.

2. The association between baseline vitamin D level and clinical outcomes in patients with COVID-19: a 7-month follow-up cohort study. The 6th International USERN Congress & Prize Awarding Festival, November 2021; Oral Presentation; Role: Presenter.

3. The risk factors and clinical outcomes associated with acute kidney injury in patients with COVID-19. The 58th ERA-EDTA International Congress, June 2021; Poster Presentation; Role: Co-author.

4. Contrast-induced nephropathy after primary percutaneous coronary intervention for acute myocardial infarction. The 17th International Congress of Nephrology, Dialysis and Transplantation, November 2019; Oral Presentation; Role: Co-author.

PEER-REVIEW EXPERIENCE

● European Heart Journal-QCCO
● Nature Scientific Reports
● Nutrition, Metabolism and Cardiovascular Diseases
● Cochrane Review
● BMC European Journal of Medical Research
● BMC Health Services Research
● BMC Emergency Medicine
● Health Science Reports
● Archives of Academic Emergency Medicine

TEACHING EXPERIENCE

(Oct. 2021 – Mar. 2022) Research Mentor, NeuroTRACT, Students' Scientific Research Center

• Mentored a team of 5 during the "Practical Research Training" course for 6-months.

(Dec. 2021) Students' Scientific Research Center, Tehran University of Medical Sciences

• Facilitated the "Writing a Research Proposal" workshop for medical students.

EXECUTIVE EXPERIENCE

(Aug. 2021) The First International Students' Cardiovascular Conference, Tehran Heart Center

• Contributed to the scientific panel and scientific board

(Oct. 2019) The 3rd Congress of Primary PCI Updates, Sina Hospital

• Contributed to the students' executive committee.

(Dec. 2018) Cardiac Primary Prevention Research Center, Tehran Heart Center

• Project manager and executor of the "Killer ECG Patterns, Diagnoses Not to Miss" Workshop.

HONORS & AWARDS

(Nov. 2021) The 6th International USERN Congress & Prize Awarding Festival

• Awarded as "The Best Junior Talk Presentation" among oral presentations.

(Dec. 2020) The 15th Sina Hospital Research Festival

• Awarded as "The Best Student Researcher of the Year" by Sina Hospital Research Development Center.

HOBBIES

Playing piano, astronomy, swimming, cooking, and hiking.